QUANTUM GROUP INC 8-K 2009
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 17, 2009
The Quantum Group, Inc.
(Exact name of registrant as specified in its charter)
3420 Fairlane Farms Road, Suite C, Wellington, Florida, 33414
(Address of Principal Executive Office) (Zip Code)
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On February 17, 2009, The Quantum Group, Inc. issued a press release which is attached hereto as Exhibit 99.1 and is incorporated by reference herein announcing that PWeR™ (Personal Wellness electronic Record) demonstrations presented at the 2009 Pri-Med South Conference and Expo were met with standing room only crowds throughout the 3-day event.
On February 18, 2009, The Quantum Group, Inc. (NYSE Amex: QGP) (www.QuantumMD.com) President & CEO Noel J. Guillama, commented on the President signing the American Recovery and Reinvestment Act of 2009 into law yesterday.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: February 19, 20009